1. Электронный научный архив УрФУ
  2. 00. Общеуниверситетские коллекции
  3. Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC
Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/51407
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKiselev, O. I.en
dc.contributor.authorDeyeva, E. G.en
dc.contributor.authorMelnicova, T. I.en
dc.contributor.authorKozeletskaia, K. N.en
dc.contributor.authorKlselev, A. S.en
dc.contributor.authorRusinov, V. L.en
dc.contributor.authorCharushin, V. N.en
dc.contributor.authorChupahin, O. N.en
dc.date.accessioned2024-03-21T08:51:10Z-
dc.date.available2024-03-21T08:51:10Z-
dc.date.issued2012-
dc.identifier.citationA new antiviral drug triazavirin: results of phase II clinical trial / O. I. Kiselev, E. G. Deyeva, T. I. Melnicova, K. N. Kozeletskaia, A. S. Klselev, V. L. Rusinov, V. N. Charushin, O. N. Chupahin // Voprosy Virusologii. — 2012. — Vol. 57. — № 6. — P. 9-12.en
dc.identifier.issn0507-4088-
dc.identifier.other43673id
dc.identifier.otherhttp://www.scopus.com/inward/record.url?partnerID=8YFLogxK&scp=84874491694m
dc.identifier.other382bb7a0-4779-4b14-8253-291c44ab11eapure_uuid
dc.identifier.urihttp://elar.urfu.ru/handle/10995/51407-
dc.description.abstractThe results of the clinical trial testing the efficacy of a new anti-influenza drug Triazavirin are presented in this work. The data of the trial were gathered during the 2010 influenza season. The treatment with oral Triazavirin significantly reduced the duration of the main clinical symptoms of influenza (intoxication, fever, respiratory symptoms), decreased the incidence of the influenza-related complications and the use of symptomatic drugs. The re-isolation rate of the influenza A and B viruses was significantly lower in the patients who were using Triazavirin. The analysis of the clinical data showed that the optimal prescribed dosage was 250 mg 3 times a day.en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherAmerican Vacuum Societyen
dc.sourceVoprosy Virusologiien
dc.subjectCLINICAL TRIALen
dc.subjectEFFICACYen
dc.subjectINFLUENZAen
dc.subjectSAFETYen
dc.subjectTRIAZAVIRINen
dc.subjectANTIVIRUS AGENTen
dc.subjectPYRROLE DERIVATIVEen
dc.subjectTRIAZAVIRINen
dc.subjectTRIAZINE DERIVATIVEen
dc.subjectADOLESCENTen
dc.subjectADULTen
dc.subjectARTICLEen
dc.subjectFEMALEen
dc.subjectHUMANen
dc.subjectINFLUENZAen
dc.subjectINFLUENZA VIRUS Aen
dc.subjectINFLUENZA VIRUS Ben
dc.subjectISOLATION AND PURIFICATIONen
dc.subjectKAPLAN MEIER METHODen
dc.subjectMALEen
dc.subjectMIDDLE AGEDen
dc.subjectPHASE 2 CLINICAL TRIALen
dc.subjectVIROLOGYen
dc.subjectADOLESCENTen
dc.subjectADULTen
dc.subjectANTIVIRAL AGENTSen
dc.subjectAZOLESen
dc.subjectFEMALEen
dc.subjectHUMANSen
dc.subjectINFLUENZA A VIRUSen
dc.subjectINFLUENZA B VIRUSen
dc.subjectINFLUENZA, HUMANen
dc.subjectKAPLAN-MEIER ESTIMATEen
dc.subjectMALEen
dc.subjectMIDDLE AGEDen
dc.subjectTRIAZINESen
dc.titleA new antiviral drug triazavirin: results of phase II clinical trialen
dc.typeArticleen
dc.typeinfo:eu-repo/semantics/publishedVersionen
dc.typeinfo:eu-repo/semantics/articleen
dc.identifier.rsi18752159-
dc.identifier.scopus84874491694-
local.affiliationFederal State Research Institute of Influenza, Ministry of Health and Social Development of the Russian Federation, St-Petersburg, Russian Federationen
local.affiliationSt-Petersburg Bekhterev Psychoneurological Research Institute, St-Petersburg, Russian Federationen
local.affiliationUral Eltsin Federal University, Ekaterinburg, Russian Federationen
local.affiliationPostovsky Institute of Organic Synthesis, Ural Branch, Russian Academy of Sciences, Ekaterinburg, Russian Federationen
local.contributor.employeeРусинов Владимир Леонидовичru
local.contributor.employeeЧарушин Валерий Николаевичru
local.contributor.employeeЧупахин Олег Николаевичru
local.description.firstpage9-
local.description.lastpage12-
local.issue6-
local.volume57-
local.contributor.departmentХимико-технологический институтru
local.identifier.pure1069878-
local.identifier.eid2-s2.0-84874491694-
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-84874491694.pdf450,54 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.